1. Regulation of insulin resistance and glucose metabolism by interaction of PIM kinases and insulin receptor substrates
   Aziz ur Rehman Aziz et al, 2018, Archives of Physiology and Biochemistry CrossRef
2. Chemerin/CMKLR1 Axis Promotes Inflammation and Pyroptosis by Activating NLRP3 Inflammasome in Diabetic Cardiomyopathy Rat
   Yebin Xie et al, 2020, Front. Physiol. CrossRef
3. Adipokines in Insulin Resistance: Current Updates
   Utpal Jagdish Dongre, 2021, Biosci., Biotech. Res. Asia CrossRef
4. Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
   Yueying Qi et al, 2021, Journal of Oncology CrossRef
5. Plasma Metabonomics in Insulin-Resistant Hypogonadic Patients Induced by Testosterone Treatment
   Lello Zolla et al, 2022, IJMS CrossRef
6. Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
   Vera Francisco et al, 2022, Biology CrossRef
7. Anti-Tumoral Effect of Chemerin on Ovarian Cancer Cell Lines Mediated by Activation of Interferon Alpha Response.
   Christa Buechler, 0 CrossRef
8. On the Need to Distinguish between Insulin-Normal and Insulin-Resistant Patients in Testosterone Therapy
   Lello Zolla, 2022, IJMS CrossRef
9. Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
   Chunye Zhang et al, 2023, Explor Dig Dis CrossRef
10. Shear-Wave Elastography for Metabolic Syndrome Patients' Non-Alcoholic Fatty Liver Disease (NAFLD) Assessment
    C. Patil Shilpa et al, 2023 CrossRef